New VITEK MS PRIME Matches Bruker Performance While Cutting Lab Processing Time
Head-to-head comparison shows bioMérieux's latest MALDI-TOF system delivers comparable accuracy with workflow advantages for high-volume labs.
Summary
Researchers compared the new VITEK MS PRIME against the established Bruker Biotyper for bacterial identification in clinical labs. Testing 154 isolates, PRIME achieved 95-96% genus-level identification versus Biotyper's 99%. Both systems showed similar performance identifying bacteria from early blood culture growth (80-84% species-level). PRIME demonstrated time savings in multi-sample workflows, reducing hands-on time from 53 to 39-40 minutes when processing multiple targets simultaneously.
Detailed Summary
Clinical microbiology labs rely on MALDI-TOF mass spectrometry for rapid bacterial identification, but workflow efficiency varies between systems. Washington University researchers conducted a comprehensive head-to-head comparison of bioMérieux's new VITEK MS PRIME against the established Bruker Biotyper standard.
The study tested 154 bacterial and yeast isolates from diverse clinical specimens using three methods: Biotyper with toothpick application, PRIME with PICKME nib, and PRIME with plastic loop. PRIME achieved 96% (PICKME) and 95% (loop) genus-level identification compared to Biotyper's 99%. For positive blood cultures processed after short 6-8 hour incubation, all systems showed comparable species-level identification rates (Biotyper: 84%, PRIME PICKME: 80%, PRIME loop: 81%).
Workflow timing revealed PRIME's key advantage in high-throughput settings. Single-target processing times were similar across methods (55-59 minutes), but PRIME significantly reduced hands-on time for multiple targets—from 53 minutes with Biotyper to 39-40 minutes with PRIME methods. This 26% time reduction stems from PRIME's ability to load up to 16 targets simultaneously while continuing analysis.
The study included 350 blood culture isolates tested by both high-experience and low-experience users, showing no significant performance differences between user skill levels. Early identification from short-incubation cultures succeeded at similar rates regardless of operator experience (89-91% for experienced vs 79-85% for novice users).
These findings suggest PRIME offers comparable diagnostic accuracy while providing meaningful workflow improvements, particularly valuable given current laboratory workforce shortages and increasing centralization demands.
Key Findings
- PRIME achieved 95-96% genus-level identification accuracy versus Biotyper's 99% across 154 clinical isolates
- Short-incubation blood cultures showed similar species identification rates: Biotyper 84%, PRIME PICKME 80%, PRIME loop 81%
- Multi-target workflow time reduced 26% with PRIME (39-40 min) versus Biotyper (53 min hands-on time)
- No significant performance difference between high-experience (89-91%) and low-experience users (79-85%) across all methods
- Single-target processing times remained comparable across all methods (55-59 minutes total)
- PRIME allows simultaneous loading of up to 16 targets while continuing analysis of other samples
- Both systems successfully identified bacteria from 6-8 hour cultures without additional extraction steps
Methodology
Prospective comparison study at Washington University testing 154 bacterial/yeast isolates from diverse clinical specimens plus 350 blood culture isolates. Three identification methods compared: Biotyper with toothpick, PRIME with PICKME nib, and PRIME with plastic loop. Workflow timing measured from sample processing to identification. Both high-experience (n=300) and low-experience users (n=50) tested short-incubation (6-8h) versus routine (18-24h) blood cultures.
Study Limitations
Study conducted at single academic center with potential site-specific workflow biases. Authors declare conflict of interest with bioMérieux funding. PRIME's target design limits unused spot reuse compared to Biotyper's more flexible target utilization. Some discrepant results required whole genome sequencing for resolution, indicating edge cases where neither system provided definitive identification.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
